Related Experiment Video

Updated: Jul 31, 2026

Candida albicans Biofilm Chip CaBChip for High-throughput Antifungal Drug Screening
08:05

Candida albicans Biofilm Chip CaBChip for High-throughput Antifungal Drug Screening

Published on: July 18, 2012

13.8K

New Technologies to Diagnose and Treat a Multidrug-Resistant Candida auris: A Patent Review

Luana Rossato1, Simone Simionatto2, Mairim Russo Serafini3

  • 1Universidade Federal da Grande Dourados-UFGD, Dourados, Mato Grosso do Sul, Brazil. luanarossato@ufgd.edu.br.

Mycopathologia
|October 4, 2022
PubMed

Insights

Multidrug-resistant Candida auris outbreaks necessitate new diagnostics and treatments. A patent review reveals increasing R&D focus on innovative therapeutic molecules and identification methods to combat this global health threat.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Patent Law

Background:

  • Candida auris is a multidrug-resistant yeast causing global hospital outbreaks.
  • Resistance to major antifungal classes limits treatment options.
  • Difficult identification and environmental persistence contribute to hospital-acquired infections.

Purpose of the Study:

  • To critically review patents for the latest therapeutic and diagnostic advancements against Candida auris.
  • To identify trends in research and development for this emerging pathogen.

Main Methods:

  • A comprehensive patent search was conducted using the Espacenet database.
  • 19 patents were initially identified, with 16 selected for final analysis.
  • Patents were categorized by country, year, and type (treatment or diagnostic).

Main Results:

  • The patent review identified 16 relevant patents concerning Candida auris.
  • A notable increase in patent filings related to new therapeutic molecules and diagnostic methods was observed in recent years.
  • Academic, government, and industry sectors show growing interest in Candida auris R&D.

Conclusions:

  • The patent landscape indicates a significant and growing effort to develop novel solutions for Candida auris.
  • There is a clear trend towards innovation in both antifungal therapies and diagnostic tools.
  • Continued R&D is critical for controlling and preventing Candida auris infections.
Keywords:
Candida aurisDiagnostic methodsTreatment

More Related Videos

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance08:45

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

13.9K
Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging03:24

Author Spotlight: Enhancing Candida albicans Detection in Catheter Infections Using Fluorescent Protein Tagging

Published on: March 22, 2024

1.6K

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...